The roles of insulin and hyperglycemia in sepsis pathogenesis
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Hyperglycemia is a risk marker of morbidity and mortality in acute critical illness, and insulin therapy seems to be beneficial in this patient group. Whether this is true for a population of sepsis patients, as such, has not been investigated in clinical trials, but evidence from in vitro studies and experimental sepsis suggests that this may be the case. The endocrinology of septic patients is characterized by a shift in the balance between insulin and its counter-regulatory hormones favoring the latter. This leads to prominent metabolic derangements composed of high release and low use of glucose, amino acids, and free fatty acids (FFA), resulting in increased blood levels of these substrates. Circulating, proinflammatory mediators further enhance this state of global catabolism. Increased levels of glucose and FFA have distinct effects on inflammatory signaling leading to additional release of proinflammatory mediators and endothelial and neutrophil dysfunction. Insulin has the inherent capability to counteract the metabolic changes observed in septic patients. Concomitantly, insulin therapy may act as a modulator of inflammatory pathways inhibiting the unspecific, inflammatory activation caused by metabolic substrates. Given these properties, insulin could conceivably be serving a dual purpose for the benefit of septic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“As FFA and glucose blood levels increase they interact, and FFA is suggested to impair glucose metabolism at various sites, one being inhibition of glucose oxidation [41] and another being stimulation of protein kinase C (PKC) [68].”
BackgroundHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Capes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187 · cited 1×
“Increased mortality in patients with hyperglycemia was also found in ischemic diseases such as myocardial infarction [6] and stroke [7], but the association could, at least partly, be explained by severity of injury and the cortisol level [8–10].”
BackgroundEsposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961 · cited 1×
“Hyperglycemia has been found to influence the production of proinflammatory cytokines acutely and chronically [110].”
BackgroundCapes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824
Inoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577
Increased mortality associated with growth hormone treatment in critically ill adults
Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411102 · Cited by 1,023
Zeng, G., & Quon, M. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118871 · Cited by 726 · cited 3×
“They found that physiologically relevant concentrations of insulin suppressed NF- B-binding activity and ICAM-1 expression, the latter dependent on stimulation of NO production by insulin, which stimulates eNO production within minutes through receptor-mediated activation of phosphatidylinositol-3 kinase (PI-3K) [87]…”
BackgroundEpinephrine-induced insulin resistance in man
Deibert, D. C., & Defronzo, R. A. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109718 · Cited by 557 · cited 1×
“Peripherally, epinephrine and -adrenergic stimulation rapidly inhibit insulin-mediated glucose uptake (IMGU) by induction of insulin resistance, mainly in the skeletal muscle [35].”
BackgroundNilsson, N. E., Kotarsky, K., Owman, C., & Olde, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00488-1 · Cited by 540
Cited by
Ayres, J. S., & Schneider, D. S. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075030 · Cited by 475
Chronic adipose tissue inflammation: all immune cells on the stage
Cildir, G., Akıncılar, S. C., & Tergaonkar, V. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.05.001 · Cited by 317
Akt and foxo Dysregulation Contribute to Infection-Induced Wasting in Drosophila
Dionne, M. S., Pham, L. N., Shirasu-Hiza, M., & Schneider, D. S. (2006) · Current Biology · doi:10.1016/j.cub.2006.08.052 · Cited by 298
The Impact of Early Hypoglycemia and Blood Glucose Variability on Outcome in Critical Illness
Bagshaw, S. M., Bellomo, R., Jacka, M. J., Egi, M., Hart, G. K., George, C., & the ANZICS CORE Management Committee (2009) · Critical Care · doi:10.1186/cc7921 · Cited by 285
“90) with greater duration of stay in hospital [36].”
BackgroundSepsis-associated encephalopathy and its differential diagnosis
Iacobone, E., Bailly-Salin, J., Polito, A., Friedman, D., Stevens, R. D., & Sharshar, T. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b6ed58 · Cited by 266
Metadata
- Authors
- Andersen, S. K., Gjedsted, J., Christiansen, C., & Tønnesen, E.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-12-04
- Volume
- 75
- Issue
- 3
- Pages
- 413-421
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2006495363
- Cited by
- 100
- References
- 14
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The roles of insulin and hyperglycemia in sepsis pathogenesis. https://app.cochat.ai/papers/10.1189/jlb.0503195
- The paper
- Andersen, S. K., Gjedsted, J., Christiansen, C., & Tønnesen, E. (2004). The roles of insulin and hyperglycemia in sepsis pathogenesis. Journal of Leukocyte Biology. https://doi.org/10.1189/jlb.0503195
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.